Filter posts

China Summit: Exploring Cross-Border Market Opportunities

Uncertainty breeds delay of innovation and volatility of markets. We are certainly seeing this play …

BIO Urges USTR To Take Action on Growing IP Barriers in Overseas Markets

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  In particular, …

How Will Brexit Impact Patients and Biotech Innovation?

The clock is beginning to run out for British Parliament to finalize a Brexit plan. …

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an …

BIO Hosts Embassy Briefing on International Economic Development

Last week BIO hosted embassy representatives from over 25 countries to debut a new report …

It Starts with One—Presentation at BIO 2018 Leads to International Agreement

A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …

#MakeHistory: Highlighting History I China

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel …

#MakeHistory: Highlighting History | South Korea

With the conclusion of the Winter Olympics earlier this year in South Korea, the pomp …

#MakeHistory: Highlighting History | Hong Kong’s New Listing Regime

Recent announcements that the Hong Kong Stock Exchange (HKEX) plans to allow the listing of …